Correct Nyxoah logo.png
Nyxoah to Participate in Annual Piper Sandler Healthcare Conference
20 nov. 2020 01h25 HE | Nyxoah
PRESS RELEASE Nyxoah to Participate in Annual Piper Sandler Healthcare Conference   Mont-Saint-Guibert, Belgium – 20th November 2020 – Nyxoah S.A. (EBR: NYXH) (“Nyxoah” or the “Company”), a...
Correct Nyxoah logo.png
First Patient Implanted in the DREAM US Pivotal IDE Study, with the Genio® System for the Treatment of Obstructive Sleep Apnea (OSA)
17 nov. 2020 01h00 HE | Nyxoah
First Patient Implanted in the DREAM US Pivotal IDE Study, with the Genio® System for the Treatment of Obstructive Sleep Apnea (OSA) DREAM is a pivotal, Investigational Device Exemption (IDE) study,...
Correct Nyxoah logo.png
Nyxoah Announces Commencement of Trading of Shares on Euronext Brussels
18 sept. 2020 01h00 HE | Nyxoah
An investment in the Offered Shares involves substantial risks and uncertainties.  Prospective investors should read the entire prospectus, and, in particular, should see "Risk Factors" for a...
Correct Nyxoah logo.png
Nyxoah Raises up to €85 million (US$100m) in Successful Initial Public Offering
17 sept. 2020 08h41 HE | Nyxoah
 An investment in the Offered Shares involves substantial risks and uncertainties.  Prospective investors should read the entire prospectus, and, in particular, should see "Risk Factors" for a...
Nyxoah Announces Int
Nyxoah Announces Intention to Launch an Initial Public Offering on Euronext Brussels
27 août 2020 01h00 HE | Nyxoah
An investment in the Offered Shares involves substantial risks and uncertainties.  Prospective investors should read the entire prospectus, and, in particular, should see "Risk Factors" for a...
Correct Nyxoah logo.png
Nyxoah receives IDE approval from the U.S. Food and Drug Administration (FDA) for its DREAM study
25 juin 2020 02h00 HE | Nyxoah
Nyxoah receives IDE approval from the U.S. Food and Drug Administration (FDA) for its DREAM study Study supporting the approval of Nyxoah’s Genio® system in the U.S. to be initiated in the coming...
Correct Nyxoah logo.png
Nyxoah announces data demonstrating the benefits and safety of its Genio® system implantation technique for the treatment of Obstructive Sleep Apnea published in Laryngoscope Investigative Otolaryngology
27 nov. 2019 02h00 HE | Nyxoah
Nyxoah announces data demonstrating the benefits and safety of its Genio® system implantation technique for the treatment of Obstructive Sleep Apnea published in Laryngoscope Investigative...
Correct Nyxoah logo.png
Nyxoah publishes positive Obstructive Sleep Apnea data from BLAST OSA study in the European Respiratory Journal
28 oct. 2019 03h00 HE | Nyxoah
  Nyxoah publishes positive Obstructive Sleep Apnea data from BLAST OSA study in the European Respiratory Journal Compelling data published in prestigious journal show safety and efficacy of the...